InvestorsHub Logo
Followers 417
Posts 52354
Boards Moderated 13
Alias Born 12/16/2001

Re: None

Monday, 02/27/2017 1:54:42 PM

Monday, February 27, 2017 1:54:42 PM

Post# of 216
MannKind: Years Before Achieving Break-Even Point
Looking For Diogenes

•Readers will see the futility that MannKind is facing with their prescription stagnation issues.

•MannKind's promises versus what they have actually accomplished for investors will be contrasted.

•107 weeks and more than 2 years marketing Afrezza the barriers continue to grow for MannKind.



http://seekingalpha.com/article/4050047-mannkind-empty-saddles-empty-promises?app=1&auth_param=1vat:1cb8kvn:d4e154e034c1c5bb880c52d360a79bdc&uprof=51#alt3

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.